ER stress: A novel therapeutic target in pancreatic cancer.

被引：0
|
作者：
Nawrocki, ST [1 ]
Carew, JS [1 ]
Pino, MS [1 ]
Highshaw, RA [1 ]
Andtbacka, RH [1 ]
Dunner, K [1 ]
Bornmann, W [1 ]
Huang, P [1 ]
Boise, LH [1 ]
Abbruzzese, JL [1 ]
McConkey, DJ [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
CLINICAL CANCER RESEARCH | 2005年 / 11卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：9038S / 9038S
页数：1
相关论文
共 50 条
  • [21] βIII-Tubulin is a Novel Therapeutic Target for the Treatment of Pancreatic Cancer
    Sharbeen, G.
    Liu, J.
    McCarroll, J.
    Youkhana, J.
    Teo, J.
    McCarthy, N.
    Goldstein, D.
    Kavallaris, M.
    Phillips, P. A.
    PANCREAS, 2013, 42 (08) : 1381 - 1381
  • [22] Nestin as a novel therapeutic target for pancreatic cancer via tumor angiogenesis
    Yamahatsu, Kazuya
    Matsuda, Yoko
    Ishiwata, Toshiyuki
    Uchida, Eiji
    Naito, Zenya
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 40 (05) : 1345 - 1357
  • [23] βIII-tubulin is a novel therapeutic target for the treatment of pancreatic cancer
    Sharbeen, G.
    Liu, J.
    Mccarroll, J.
    Youkhana, J.
    Teo, J.
    Mccarthy, N.
    Goldstein, D.
    Kavallaris, M.
    Phillips, P. A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 12 - 12
  • [24] Netrin-1 is a Novel Therapeutic Target for Metastatic Pancreatic Cancer
    Casabianca, Anthony S.
    Dudgeon, Crissy
    Soliman, Fady
    Withers, Tracy
    Mehlen, Patrick
    Carpizo, Darren S.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2020, 231 (04) : S275 - S275
  • [25] βIVb-Tubulin is a Novel Therapeutic Target for the Treatment of Pancreatic Cancer
    Sharbeen, G.
    Liu, J.
    McCarroll, J.
    Limbri, L.
    Youkhana, J.
    Goldstein, D.
    Kavallaris, M.
    Phillips, P.
    PANCREAS, 2015, 44 (08) : 1414 - 1414
  • [26] Epidermal growth factor receptor: Is a novel therapeutic target for pancreatic cancer?
    Dhar, A
    Mehta, S
    Banerjee, S
    Dhar, K
    Dhar, G
    Sengupta, K
    Ray, G
    Banerjee, SK
    Campbell, DR
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2005, 10 : 1763 - 1767
  • [27] A novel NK cell-targeted therapeutic strategy against pancreatic cancer.
    Mehla, Kamiya
    Caffrey, Thomas C.
    O'Connel, Kelly A.
    Madiyalakan, Raghupathy
    Nicodemus, Christopher F.
    Hollingsworth, Michael A.
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (04) : 34 - 35
  • [28] PCNA-I1 is identified as a novel therapeutic agent in pancreatic cancer.
    Yamashita, Hironari
    Ono, Hiroaki
    Takizawa, Kotaro
    Watanabe, Shuichi
    Ogawa, Kosuke
    Asano, Daisuke
    Ishikawa, Yoshiya
    Ueda, Hiroki
    Akahoshi, Keiichi
    Kudo, Atsushi
    Akiyama, Yoshimitsu
    Tanaka, Shinji
    Tanabe, Minoru
    CANCER SCIENCE, 2024, 115 : 1930 - 1930
  • [29] DYRK2 is a novel therapeutic target in ER negative breast cancer
    Edwards, J.
    Baillie, G.
    Quinn, J.
    Monreno, R.
    Banerjee, S.
    Tomkinson, N.
    MacKay, S.
    De La Vega, L.
    CANCER RESEARCH, 2019, 79 (04)
  • [30] ER-α36: a novel biomarker and potential therapeutic target in breast cancer
    Su, Xingyun
    Xu, Xin
    Li, Guangliang
    Lin, Bingyi
    Cao, Jiang
    Teng, Lisong
    ONCOTARGETS AND THERAPY, 2014, 7 : 1525 - 1533
12345